Antiplatelet Agents for the Prevention of Cardiovascular Disease in Diabetes Mellitus

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.4, Iss.2, 2004-01, pp. : 87-106

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiplatelet Agents in the Prevention of Cardiovascular Morbidity and Mortality in Older Patients With Vascular Disease

By Aronow W.S.

Drugs & Aging, Vol. 15, Iss. 2, 1999-08 ,pp. : 91-101

Adis International

Access to resources Recommend Favorite

Role of aspirin in the primary prevention of cardiovascular disease in diabetes mellitus: a meta-analysis

By Younis Naveed Williams Steven Ammori Basil Soran Handrean

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 9, 2010-06 ,pp. : 1459-1466

Informa Healthcare

Access to resources Recommend Favorite

Cardiovascular risk and prevention in diabetes mellitus

By Roberts Aled W

Clinical Medicine, Vol. 10, Iss. 5, 2010-10 ,pp. : 495-499

Royal College Of Physicians

Access to resources Recommend Favorite

Approaches to Prevention of Cardiovascular Complications and Events in Diabetes Mellitus

By Coccheri Sergio

Drugs, Vol. 67, Iss. 7, 2007-01 ,pp. : 997-1026

Adis International

Access to resources Recommend Favorite

Challenges and Perspectives of Antiplatelet Therapy in Patients with Diabetes Mellitus and Coronary Artery Disease

Current Pharmaceutical Design, Vol. 18, Iss. 33, 2012-11 ,pp. : 5273-5293

Bentham Science Publishers

Access to resources Recommend Favorite